ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 674347 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 674347; 2) Community: the network communities that were significantly associated with the response to NSC 674347; 3) Molecule: the relationships between components within communities and NSC 674347; 4) MDR: the compounds that were significantly associated with the NSC 674347.

NSC Compound Enrichment Correlation
NSC 725775 6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 0.0454469012959173 0.6189629
NSC 727354 6-[(4-FMOCamino)-1-butyl]-5,6-dihydro-2,3-dimethoxy-8,9-meth ylenedioxy-5,11-dioxo-11H-indeno[1,2-c-isoquinoline 0.0454469012959173 0.58579422
NSC 730478 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-5-androsten-3.beta.,17.beta.-diol 0.0454469012959173 -0.077553458
NSC 73233 Null 0.0454469012959173 0.040497051
NSC 735037 Camptothecin Derivative 0.0454469012959173 0.73511599
NSC 742149 Bisarylpurine 0.0454469012959173 0.077774641
NSC 745677 Null 0.0454469012959173 -0.25456837
NSC 749518 1-[(2Z)-3-amino-3-phenylprop-2-enoyl]-3-phenyl-1H-pyrazol-5-amine 0.0454469012959173 0.33728449
NSC 750501 1,5-bis[4-(N-butylamidino)phenoxy]-3-tiapentane dihydrochloride 0.0454469012959173 -0.091032161
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.0454469012959173 0.73331042
Total:53  Current:52    [First] [Prev] [Next] [Last]